Bill Status of SB3221

  1. Home
  2. Legislation
  3. Bill Status

SB3221 - 104th General Assembly

CONTROLLED SUB-XYLAZINE
Last Action
2/02/2026 - Senate: Referred to Assignments
Senate Sponsors
Sen. Julie A. Morrison
Statutes Amended In Order of Appearance
720 ILCS 570/102from Ch. 56 1/2, par. 1102
720 ILCS 570/204from Ch. 56 1/2, par. 1204
720 ILCS 570/206from Ch. 56 1/2, par. 1206
720 ILCS 570/208from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Makes structural and other changes to the list of controlled substances. Adds xylazine as a Class III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian. Defines "isomer". Effective January 1, 2027.
Actions
Date Chamber Action
2/02/2026 Senate Filed with Secretary by Sen. Julie A. Morrison
2/02/2026 Senate First Reading
2/02/2026 Senate Referred to Assignments